Holen Sie sich die Stockscreener-App
97.64
0.75%
-0.74
Handel nachbörslich:
97.64
Schlusskurs vom Vortag:
$98.38
Offen:
$98.95
24-Stunden-Volumen:
9.72M
Relative Volume:
1.12
Marktkapitalisierung:
$144.75B
Einnahmen:
$19.35B
Nettoeinkommen (Verlust:
$2.78B
KGV:
52.23
EPS:
1.8696
Netto-Cashflow:
$3.82B
1W Leistung:
+3.09%
1M Leistung:
+5.52%
6M Leistung:
-5.17%
1J Leistung:
+1.76%
1-Tages-Spanne:
$97.23
$99.09
1-Wochen-Bereich:
$93.86
$100.90
52-Wochen-Spanne:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific plans move to former Scorpion building - Santa Clarita Valley Signal
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch - TipRanks
Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition - Benzinga
What technical signals suggest for Boston Scientific Corporation stock2025 Trading Recap & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Boston Scientific Corp.: How a Medtech Powerhouse Is Re?Wiring the Future of Minimally Invasive Care - AD HOC NEWS
Boston Scientific reportedly plans to consolidate some Texas operations with new facility - MassDevice
Boston Scientific Earnings Preview: What to Expect - Yahoo Finance
Can Boston Scientific Corporation stock continue upward trendDividend Aristocrats List & Small Capital Trading Growth - ulpravda.ru
Boston Scientific (BSX) Just Overtook the 50-Day Moving Average - Yahoo Finance
If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now - Yahoo Finance
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
We Think Boston Scientific (NYSE:BSX) Can Manage Its Debt With Ease - Yahoo Finance
Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors - DirectorsTalk Interviews
Boston Scientific Stock: Steady Beat, Subtle Volatility – What The Market Is Really Pricing In - AD HOC NEWS
JARISLOWSKY FRASER Ltd Trims Stake in Boston Scientific Corporation $BSX - MarketBeat
Synergy Asset Management LLC Acquires 479,593 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Is Quietly Winning Wall Street – But Is BSX Actually Worth Your Money? - AD HOC NEWS
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results - Finviz
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results – Company AnnouncementFT.com - Financial Times
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Vanderbilt University Has $2.55 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? - The Globe and Mail
Calamos Wealth Management LLC Buys 53,252 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Boston Trust Walden Corp - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
Does Boston Scientific (NYSE:BSX) Deserve A Spot On Your Watchlist? - Yahoo Finance
Boston Scientific Corp. stock: quiet tape, loud expectations as Wall Street leans bullish - AD HOC NEWS
Sowell Financial Services LLC Sells 28,806 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Position Lessened by Ethic Inc. - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5 - Quantisnow
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook - Insider Monkey
VCI Wealth Management LLC Invests $1.26 Million in Boston Scientific Corporation $BSX - MarketBeat
Norden Group LLC Increases Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Brookstone Capital Management - MarketBeat
What Analysts Think Is Changing In The Boston Scientific Growth Story - Yahoo Finance
Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors’ Thesis? - Yahoo Finance
Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025? - simplywall.st
Boston Scientific (BSX) Stock After Hours on Dec. 24, 2025: Key Moves, Today’s Fresh Analysis, and What to Watch Before Markets Reopen - ts2.tech
Boston Scientific (BSX): Assessing Valuation After a Strong Multi‑Year Run and Recent Pullback - Yahoo Finance
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? - Yahoo Finance
Boston Scientific Corporation $BSX is Munro Partners' 8th Largest Position - MarketBeat
Exchange Traded Concepts LLC Boosts Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific head of cardiac rhythm management, diagnostics to retire, successor named - MassDevice
Westwind Capital Takes $13.80 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Should You Hold On To BSX Stock Despite Its Premium Valuation? - Finviz
Is Boston Scientific Corp. (BSX) Positioned for Solid, Durable Growth? - Insider Monkey
Boston Scientific Corporation's (NYSE:BSX) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):